Introduction
The clinicopathologic classification, diagnosis, and management of Spitzoid melanocytic lesions is one of the most problematic topics in dermato-oncology and dermatopathology.
After earlier anecdotal reports [1, 2] , the controversial history of these controversial lesions began in 1948 when Sophie Spitz described 13 cases of what she called "juvenile melanoma," underlining its presumably good prognosis because only one case of her series had proven fatal [3] . During the following forty years, however, the entity described by Sophie Spitz was thought to be completely benign, with metastasizing cases being intuitively considered as cases of melanomas simulating Spitz nevus (Spitzoid melanoma) [4] . In 1989, Smith and co-worker described the so-called "Spitz nevus with atypia and metastasis" or "malignant Spitz nevus," i.e., a kind of lesion showing histopathologic features not enough for a diagnosis of malignancy, yet capable of nodal metastasis, usually with no further dissemination [5] . This apparently contradictory concept was then set forth by Barnhill with the diagnostic category of "metastasizing Spitz tumor" [6] , or "atypical Spitz nevus/tumor" [7] . To date, while some opinion leaders maintain that there are only two diagnostic categories (nevus and melanoma) and that every "abnormal" behavior is simply a diagnostic mistake [8] , some others suggest that Spitzoid lesions are indeed a "morpho-biologic spectrum" of lesions ranging from benignity to full-blown malignancy [9] , and sharing a peculiar genetic profile, with chromosome rearrangements involving kinase fusions [10] . Intermediate lesions within such a spectrum eventually show: i) an equivocal histomorphology, featuring a diagnostic agreement among experts which is consistently lower than for "conventional" (non-Spitzoid) melanocytic neoplasms [7, 11] ;
ii) peculiar clinical features and behavior with a relatively high incidence in prepubescent patients [12] and a higher incidence of regional (sentinel) node involvement [13] but a better prognosis than "conventional" (non-Spitzoid) melanoma of the same thickness/stage [14] (possible lowgrade malignancies [11] ).
Hypopigmented atypical Spitzoid neoplasms (atypical Spitz nevi, atypical Spitz tumors, Spitzoid melanoma): a clinicopathological update
allow clinicians to increasingly identify and excise pigmented spindle cell Spitz nevus and Reed nevus (which are basically the same clinicopathological entity), to such an extent that the brown-black plaque-like "variant" is surprisingly becoming the most common (and therefore "typical") Spitz nevus encountered in clinico-dermoscopic-pathologic studies [15] [16] [17] . The present paper will focus on the clinicopathological features of papulonodular hypopigmented Spitzoid lesions, which are "atypical" with a much greater frequency than their plaque-like heavily pigmented counterpart [16, 17] .
The proposed classification systems for Spitzoid neoplasms
The dermatopathologist's mission is to provide an accurate, specific, and comprehensive diagnosis, thereby enabling the clinician to estimate the prognosis and develop the optimal plan of treatment and follow up for any single patient.
There is little doubt that the simple designation "benign" vs "malignant" provides the clinician with all of the necessary information for the patients' care. A. Bernard Ackerman taught us that each pigmented lesion may have only three diagnoses: "melanoma," "nevus" or "I don't know," with the "I don't know" cases to be referred to an expert who will be finally able to place them into either of the first two entities. According to this view, the adjective "atypical" is redundant and useless, because any Spitz nevus is "atypical" by definition; nevertheless, it can be differentiated from its malignant simulator (i.e., Spitzoid melanoma) according to a well defined set of histologic criteria; every Spitzoid (and non-Spitzoid) melanocytic proliferation behaves as either a benign or a malignant neoplasm which we can be unable to correctly categorize simply because our brain can fail to correctly apply the diagnostic criteria [8] .
A.B. Ackerman's approach delivers a clear-cut message to the clinicians; nevertheless, it carries at least two major problems, which are still waiting to be overcome. The first problem is purely morphologic: by assuming that Spitz nevus is a simulator of melanoma (Spitz nevus as a pseudomalignancy) and that melanoma resembling Spitz nevus is a simulator of its simulator (Spitzoid melanoma as a pseudopseudomalignancy), it is not surprising that the diagnosis of such lesions is a quandary even among experts who may be indeed unable to place an "I don't know" lesion into a either "nevus" or "melanoma" category [7, 11, 18] . was concluded that the cases were all malignant, albeit clearly different from "conventional" melanoma because of a great thickness associated with a relatively low metastatic rate [18] .
Because of all these uncertainties and under medicolegal pressure, a dichotomic "benign vs malignant" approach unavoidably leads to a frequent overdiagnosis of melanoma or, else, to the cautious suggestion of a management as per melanoma for lesions that, even if malignant, are biologically different from "conventional" melanoma.
These reasons led Barnhill to set forth a three-tiered classification system by assuming an "intermediate" category
("atypical Spitz nevus/tumor") between Spitz nevus and melanoma [6, 7] . Within Barnhill's "intermediate" category, the risk of malignancy of each lesion was considered as allegedly proportional to its "deviance" from the conventional stereotype of the Spitz nevus.
As an extreme consequence of this view, in 2006 Barnhill proposed that every Spitzoid lesion could be actually classified "intermediate" and thereby designated as "tumor"
(without or with atypical features) [19] : more explicitly, all Spitzoid lesions could be virtually "non-benign," with the new dichotomic approach thus being "tumor vs melanoma."
The message to the clinician, which stems from Barnhill's approach is that basically all Spitzoid lesions represent a harmful occurrence, and in our opinion, this is too much.
In keeping with the concept of Spitzoid neoplasms as a morpho-biological spectrum, we have adopted a four-tiered classification system proposed by Da Forno [20] and encompassing: i) Spitz nevus; ii) atypical Spitz nevus; iii) (atypical) Spitz tumor; iv) Spitzoid melanoma [17] . The histopathologic criteria for the differential diagnosis between the two "intermediate" categories of the spectrum-atypical Spitz nevus and Spitz tumor-are provided in Table 1 . Briefly, a Spitz tumor is-by definition-"tumorigenic," i.e., it is characterized by a nodular silhouette made by confluent sheets of cells in the dermis without intervening collagen, and/or (nontraumatic) ulceration, and/or relevant mitotic activity [17] .
The decision-making process following a diagnosis based on our classification system is itemized in the "Guidelines for management" section.
An algorithm for the clinical diagnosis of Spitzoid neoplasms
It is commonly said that Spitz nevus can show all the "local" dermoscopic features of melanoma, but in a more or less tidy fashion [15, 17] . The occurrence of an atypical (melanomalike) dermoscopic pattern in Spitz nevus is also possible.
However, the relationship between dermoscopic and histopathologic atypia is not absolute, inasmuch as dermoscopically atypical lesions are not necessarily histopathologically atypical as well; conversely, it is well known that amelanotic melanoma can show a tidy ("Spitz nevus-like") dermoscopic appearance [21] .
Since a fully reliable clinico-dermoscopic distinction between Spitz nevus and melanoma is not possible, surgical excision is warranted for all lesions with Spitzoid features. There is, however, a remarkable exception to this rule:
since in pre-puberty Spitz nevus is relatively common [12] whereas melanoma is exceedingly rare [22] , a Spitzoid lesion in patients younger than 12 years can be managed conservatively unless it stands as atypical on clinical and/or on dermoscopic grounds, either at the baseline or during follow up [12] . For the above, the clinical evaluation of such lesions can be accomplished according to the following algorithm:
1. Recognition of a Spitzoid melanocytic lesion on dermoscopy: this is enough to warrant surgical excision after puberty.
Recognition of atypical clinicodermoscopic features in a
Spitzoid melanocytic lesion: this is the threshold for surgical excision in prepubescent patients.
Recognition of atypical clinicodermoscopic features dur-
ing follow up of a Spitzoid melanocytic lesion in prepubescent patients.
The following sections will focus on hypopigmented Spitzoid lesions; nevertheless, the above-specified algorithm must be implemented for all Spitzoid lesions, irrespective of the amount of their pigmentation.
Recognition of a hypopigmented Spitzoid lesion
A hypopigmented Spitzoid melanocytic neoplasm can be typified by at least one of the following:
1. Homogeneous pink color: sometimes associated with a brownish hue or remnant(s) of brown pigmentation.
2. Dotted vascular pattern: short capillary loops visible as pinpoint dots, best appreciated with non-contact dermoscopy. 
Recognition of atypical clinico dermoscopic features during followup of a Spitzoid melanocytic lesion in prepubescent patients.
Dermoscopic monitoring of Spitzoid proliferations can be recommended only for plaque-like or dome-shaped dermoscopically symmetric lesions before puberty [12] : the suggested protocol is based on clinico-dermoscopic controls every three to six months [25] .
A completely benign hypopigmented lesion is expected to enlarge, even very rapidly but always very symmetrically, and then to slowly involute, either completely [26] or up to a "dermal nevus-like" homogeneous light brown pattern [27, 28] . Abnormal dermo- scopic digital follow up findings (an example is given in arising in the background of a Spitz nevus [17] , just like already suggested for melanoma arising in Spitz tumor [29] . The suggested management for both pediatric-type and adult-type Spitzoid melanoma is obviously the same as for "conventional" melanoma.
Guidelines for management

Conclusions
The introduction of dermoscopy has significantly changed the clinical diorama of Spitzoid lesions. Since there are still many controversial points in the histopathologic categorization of these lesions, clinicopathologic correlation must be the mainstay for their diagnosis and proper management.
